Hansa Biopharma AB

Quick facts

Marketed products

• Anti-CD20 antibodies
• Cyclophosphamide (CYC) · Oncology, Immunology
  Cyclophosphamide is an alkylating agent that cross-links DNA strands, preventing cell division and causing cell death in rapidly dividing cells.
• Ides · Immunology

Phase 2 pipeline

• IdeS

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Hansa Biopharma AB portfolio CI brief
• Hansa Biopharma AB pipeline updates RSS